First Mpox Clade Ib Case Detected in Ecuador — National Alert Activated

Ecuador has detected its first case of the more contagious Mpox variant, and the government has responded by activating a national health alert.

On April 2, 2026, the Ministry of Public Health (Ministerio de Salud Publica -- MSP) confirmed that an imported case of Mpox Clade Ib had been identified in the country. The case was detected through genomic sequencing performed by INSPI (Instituto Nacional de Investigacion en Salud Publica -- Ecuador's national public health research institute), which confirmed the specific viral clade.

What Is Clade Ib

Mpox (formerly known as monkeypox) has multiple genetic variants, or "clades." The distinction matters because they behave differently:

• Clade II (including IIa and IIb) was responsible for the global outbreak in 2022-2023. It spread primarily through close physical contact and had a relatively low fatality rate in countries with good healthcare access
• Clade I (including Ia and Ib) has been endemic in Central Africa. Clade Ib specifically has driven a significant outbreak in the Democratic Republic of Congo and neighboring countries since 2023. It is considered more transmissible than Clade II and has shown higher severity in some populations

The World Health Organization declared the Clade Ib outbreak a Public Health Emergency of International Concern (PHEIC) in August 2024 -- a designation reserved for events that pose a risk of international spread and require a coordinated global response.

Ecuador's case is an imported case, meaning the individual contracted the virus outside Ecuador and was identified after arrival. This is not community transmission within the country.

Symptoms to Know

Mpox symptoms typically appear 5 to 21 days after exposure. The illness generally progresses through distinct stages:

Early symptoms (1-5 days):

• Fever
• Intense headache
• Muscle aches and back pain
• Swollen lymph nodes (a distinguishing feature from similar conditions)
• Fatigue and general malaise

Rash phase (1-3 weeks):

• Skin lesions that progress from flat spots to raised bumps to fluid-filled blisters, then crust over
• Lesions commonly appear on the face, palms of hands, and soles of feet -- though they can appear anywhere on the body
• Lesions can also occur on mucous membranes (mouth, genitals)
• The rash can be painful or itchy

Most people recover fully within 2 to 4 weeks. Severe cases are more common in individuals with compromised immune systems, young children, and pregnant women.

How It Spreads

Mpox spreads through:

• Close, prolonged skin-to-skin contact with an infected person's rash, scabs, or body fluids
• Respiratory droplets during prolonged face-to-face contact
• Contaminated materials -- touching bedding, clothing, or towels used by an infected person
• Sexual and intimate contact -- a significant transmission pathway in recent outbreaks

Importantly, Mpox is not as easily transmissible as COVID-19 or influenza. It requires more direct and prolonged contact. You are unlikely to contract it from casual interactions like passing someone on the street, sitting in a restaurant, or using public transportation.

Ecuador's Response

The Ministry of Health activated several response measures:

• National epidemiological alert -- all hospitals, clinics, and health centers are on notice to identify and report suspected cases
• Enhanced surveillance at points of entry -- airports and land border crossings have been alerted to screen for symptoms
• Contact tracing for the confirmed case -- identifying and monitoring individuals who had close contact with the patient
• Laboratory capacity -- INSPI has confirmed it can perform genomic sequencing to identify Mpox clades, meaning future cases can be rapidly classified
• Communication campaign -- public health messaging about symptoms, prevention, and when to seek medical attention

The government emphasized that the detection of a single imported case does not indicate community spread and that the response measures are precautionary.

Context: Ecuador's Mpox History

Ecuador has dealt with Mpox before. During the 2022-2023 global outbreak of Clade IIb, Ecuador recorded cases primarily in Quito and Guayaquil. That outbreak was contained through contact tracing and public health measures, and case counts remained relatively low compared to larger countries.

The Clade Ib detection is significant because it represents the arrival of a different, more concerning variant -- but Ecuador's public health infrastructure has experience managing Mpox cases and the response protocols are already established.

What This Means for Expats

• This is not a cause for alarm, but it is worth being aware of. A single imported case is not an outbreak. Ecuador's health system identified it quickly, confirmed the clade through genomic sequencing, and activated appropriate protocols. That is the system working as it should
• Know the symptoms. If you develop an unexplained rash -- particularly with lesions on your face, palms, or soles -- combined with fever and swollen lymph nodes, seek medical attention and mention Mpox as a possibility. Early identification helps both your treatment and public health response
• The risk to the general expat population is very low. Mpox requires close, prolonged contact for transmission. Standard hygiene practices -- handwashing, avoiding contact with unfamiliar skin lesions, not sharing towels or bedding with symptomatic individuals -- provide effective protection
• Vaccination exists but is limited. The Jynneos vaccine (also called MVA-BN or Imvanex) is effective against Mpox. Availability in Ecuador is limited, but if you are in a higher-risk category, consult with your healthcare provider about options. The U.S. Embassy health unit may have additional guidance for American citizens
• Do not let this change your travel plans. The WHO's PHEIC designation relates to the global situation, primarily the outbreak in Central and East Africa. One imported case in Ecuador does not create a travel risk

Health contacts:

• ECU 911 -- for medical emergencies
• MSP hotline: 171 -- Ministry of Health information line
• U.S. Embassy health information: ec.usembassy.gov

Sources: Teleamazonas, Infobae, Primicias